Papers associated with rbl1 (and Disease Ontology)

???displayGene.coCitedPapers???
Show all rbl1 papers

???pagination.result.count???

???pagination.result.page??? 1

Sort Newest To Oldest

Sort Oldest To Newest

	RBL1 (p107) functions as tumor suppressor in glioblastoma and small-cell pancreatic neuroendocrine carcinoma in Xenopus tropicalis., Naert T, Dimitrakopoulou D, Tulkens D, Demuynck S, Carron M, Noelanders R, Eeckhout L, Van Isterdael G, Deforce D, Vanhove C, Van Dorpe J, Creytens D, Vleminckx K, Vleminckx K., Oncogene. March 1, 2020; 39 (13): 2692-2706.
	CRISPR/Cas9 disease models in zebrafish and Xenopus: The genetic renaissance of fish and frogs., Naert T, Vleminckx K, Vleminckx K., Drug Discov Today Technol. August 1, 2018; 28 41-52.
	TALENs and CRISPR/Cas9 fuel genetically engineered clinically relevant Xenopus tropicalis tumor models., Naert T, Van Nieuwenhuysen T, Vleminckx K, Vleminckx K., Genesis. January 1, 2017; 55 (1-2):
	CRISPR/Cas9 mediated knockout of rb1 and rbl1 leads to rapid and penetrant retinoblastoma development in Xenopus tropicalis., Naert T, Colpaert R, Van Nieuwenhuysen T, Dimitrakopoulou D, Leoen J, Haustraete J, Boel A, Steyaert W, Lepez T, Deforce D, Willaert A, Creytens D, Vleminckx K, Vleminckx K., Sci Rep. October 14, 2016; 6 35264.

???pagination.result.page??? 1